When you graze a knee, the repair work begins within hours. Cells at the edge of the wound receive chemical signals, divide to close the gap, and stop once the skin is whole again. The same quiet housekeeping goes on throughout the body: the cells lining the intestine are replaced within days, and new blood cells are produced continuously in the bone marrow.
Our body has a natural way of controlling cell growth. When new cells are needed, existing cells divide to replace old or damaged ones. Once this work is complete, the process normally slows down or stops. But sometimes, changes in a cell's DNA affect how this system works. The affected cell may continue dividing when it is no longer needed, and over time, these abnormal cells can develop into cancer.
So what actually happens inside the body as cancer develops? The answer is not a single event but a gradual build-up of changes, usually over years. This article follows that process from the healthy cell through to diagnosis and treatment, explaining the science in plain language and being clear about where cancers differ from one another and where medicine cannot offer certainty.
The human body is made of trillions of cells, and almost every one carries a full copy of the same DNA. Within it, genes act as instructions for building the proteins that do the cell's work. Think of DNA as an enormous recipe library: each cell reads only the recipes it needs, but all of them must be copied accurately whenever a cell divides.
Division follows an ordered sequence called the cell cycle. The cell grows, copies its DNA, checks the copy, and only then splits in two. Built-in checkpoints act like inspectors, pausing the process if the DNA is damaged or conditions are not right. Whether a cell enters the cycle at all depends on signals from its surroundings, such as growth factors and hormones, and normal cells generally stop growing when they meet neighbouring cells.
Copying billions of DNA letters inevitably produces occasional errors, and everyday exposures damage DNA too. Repair proteins constantly proofread and fix it. When damage is too severe to mend, a healthy cell triggers apoptosis, or programmed cell death, a tidy self-dismantling that does not harm nearby tissue. Apoptosis is not only a safety measure; it also shapes the body during development, for example by separating the fingers in the womb. Together, growth signals, checkpoints, repair, and apoptosis keep tissues the right size and largely free of faulty cells.
As the National Cancer Institute explains, cancer is a genetic disease: it is caused by changes to the genes that control how cells grow and divide. These changes, called mutations, can arise from errors made as cells divide, from damage caused by environmental exposures such as the chemicals in tobacco smoke or ultraviolet rays, or from genetic changes inherited from a parent.
The difference between inherited and acquired changes matters. Inherited (germline) variants are present in every cell from birth and can raise a person's risk, but they do not make cancer certain. Acquired (somatic) mutations arise during a lifetime in a single cell and pass only to that cell's descendants; most cancers are driven by these. Importantly, not every mutation causes cancer. Most are harmless, are repaired, or lead to the cell's removal. The changes that promote cancer tend to occur in three families of genes, and usually several must accumulate in the same cell.
Proto-oncogenes are the body's growth accelerators. In healthy cells, they encourage division and survival when the body needs it. If a proto-oncogene is altered, or becomes more active than normal, it can turn into an oncogene, like an accelerator pedal stuck down: the cell keeps receiving "grow" instructions when none have been given. A change in just one copy of the gene can sometimes be enough.
These are the brakes. They slow cell division, help hold the cell cycle at its checkpoints, and can trigger apoptosis when damage is found. Often both copies of a tumour suppressor gene must be disabled before the brake fails, although inheriting one faulty copy gives a head start. TP53 is among the most frequently altered genes across many types of cancer.
Repair genes are the maintenance crew. When they are faulty, DNA errors are not fixed properly, so further mutations build up faster in other genes. Inherited variants in BRCA1 and BRCA2, which help repair certain kinds of DNA breaks, are well-known examples and are linked with a higher risk of breast, ovarian, and some other cancers.
Cancer development is often described as a series of stages. This is a simplification rather than a fixed sequence followed by every cancer: the steps overlap, can occur in a different order, and differ between cancer types and between individuals. The whole process generally takes years rather than weeks.
A cell's DNA is altered, whether by a copying error, a carcinogen, or an inherited predisposition. Usually this goes nowhere, because repair systems fix the damage or the cell is eliminated. Occasionally the altered cell survives, and the change is copied into every cell it produces.
If the change switches on an oncogene or disables a tumour suppressor, the cell's growth control is compromised. It may divide without being told to, ignore signals to stop, and keep going even when crowded by neighbours.
A cell this disrupted would normally detect the problem and undergo apoptosis. In developing cancer, the machinery that senses damage or carries out cell death is itself impaired, so abnormal cells that should have been removed persist and multiply.
Each division is another chance for new mutations, particularly when repair genes are affected. Over time, cancer cells may acquire duplications and deletions of parts of chromosomes, change the way they use nutrients, and diversify, so that even within one tumour, different cells carry different genetic changes. The body's ability to clear damaged cells also declines with age, which is part of why cancer becomes more common later in life.
The defining step is invasion. Rather than staying within their original layer of tissue, cancer cells push into the tissue around them. The word "may" is deliberate: some abnormal growths never gain this ability, and invasion is what separates a cancer from a non-cancerous growth.
No. Doctors use several terms to describe tissue changes, and the differences are important.
Hyperplasia means cells multiply faster than normal, and extra cells accumulate, but the cells and the way the tissue is organised still look normal under the microscope. It can be caused by chronic irritation or hormonal stimulation and often settles when the cause is removed.
Dysplasia is a step further. Extra cells build up, and they look abnormal and are arranged abnormally. In general, the more abnormal the cells look, the greater the chance that cancer will eventually form, but many dysplastic changes never progress. Some are monitored and others treated. An unusual (dysplastic) mole is a familiar example; most do not become melanoma.
Benign tumours do not invade nearby tissue or spread, and they usually do not grow back after removal. They are not always harmless: a benign tumour in the brain, for instance, can cause serious problems through its size and position, and some growths, such as certain bowel polyps, can change into cancer over time, which is why they are often removed.
Malignant tumours are cancerous. They invade surrounding tissue and may spread to other parts of the body.
Not every cancer forms a solid lump, either. Leukaemias, cancers of the blood-forming tissue in the bone marrow, generally do not develop as a single solid tumour. Instead, large numbers of abnormal white blood cells build up in the blood and bone marrow, crowding out normal blood cells.
A tumour begins with a single altered cell that divides, and whose daughter cells divide in turn. The growth is invisible at first; a mass has to contain many millions of cells before it can be felt or seen on a scan.
Cells need oxygen and nutrients, and a small cluster can get them by diffusion from nearby vessels. Beyond a tiny size, that is no longer enough. Tumours solve this through angiogenesis: cancer cells release signals that make new blood vessels grow towards them. These vessels supply oxygen and nutrients and carry away waste, although they are often irregular and leaky. Some treatments aim to block this process, in effect starving the tumour of its supply.
A tumour is not just a ball of cancer cells. It is surrounded by immune cells, supporting fibroblast cells, blood vessels and signalling molecules, together called the tumour microenvironment. Cancer cells can reshape this environment, and the environment in turn influences how the cancer grows and spreads.
Growth rates vary widely. Some tumours enlarge slowly over years; others double in size quickly. The pace depends on the cancer type, how abnormal the cells are, their genetic features, and the surrounding environment, and many cells within a tumour die along the way, so growth is rarely steady.
The immune system is constantly patrolling. Cells such as T cells and natural killer cells can recognise abnormal proteins on the surface of damaged or mutated cells and destroy them, a process often called immune surveillance. It probably eliminates many abnormal cells before they ever cause trouble.
Cancers that become established have, in effect, found ways around this. Some cancer cells display fewer of the markers immune cells look for. Others use "checkpoint" proteins, which normally prevent the immune system from attacking healthy tissue, to send a "do not attack" signal. Some release substances or recruit other cells that dampen immune activity, and some persuade immune cells to protect the tumour rather than attack it. Because cancer cells began as the body's own cells, they can be harder to distinguish from healthy ones than a virus or bacterium would be.
This understanding underlies immunotherapy. Checkpoint inhibitors, for example, release the brakes on immune cells, while CAR T-cell therapy uses a patient's own engineered T cells against certain blood cancers. Immunotherapy is not suitable or effective for every type of cancer. It works well in some cancers and in some patients, little in others, and it can cause its own side effects when the immune system becomes overactive.
Spread, called metastasis, is a multi-step process, and it happens in only some cancers and only some of the time.
First, cells loosen their attachments to the primary tumour and its neighbours. They then invade local tissue, partly by breaking down the supporting framework around cells. Next, some enter nearby blood or lymphatic vessels. Once in circulation, they are carried to other parts of the body, but this is a hazardous journey: most cells that enter the bloodstream die, damaged by physical forces or destroyed by the immune system. The rare survivors lodge in small vessels, move out into the surrounding tissue, and must then adapt to an unfamiliar environment. Some begin to grow into new, metastatic tumours; others lie dormant for long periods.
This is why not every circulating cancer cell causes metastasis, and why some cancers rarely spread at all. Basal cell skin cancers, for instance, seldom metastasise.
A metastatic tumour keeps the identity of the cancer it came from. Breast cancer that spreads to the lungs is metastatic, not primary lung cancer. Under the microscope, the cells in the lung still resemble breast cancer cells and share molecular features with them, and treatment is generally guided by the original cancer type.
Cancer causes problems in a few main ways: by growing into or pressing on nearby structures, by crowding out normal cells, and by affecting the body more widely through changes in metabolism and inflammation. The effects depend on where it is.
In lung cancer, a tumour can narrow or block airways and irritate the lining, causing a persistent cough, breathlessness, or repeated chest infections. In colorectal cancer, a growth can narrow the bowel and bleed slowly, leading to changed bowel habits and iron-deficiency anaemia. Brain tumours, whether benign or malignant, grow within the fixed space of the skull, so pressure or disruption of nearby tissue can cause headaches, seizures, or changes in vision, speech, balance or strength, depending on location. In leukaemia, abnormal cells crowd the bone marrow, so fewer healthy red cells, white cells and platelets are made, which can cause tiredness, frequent infections, and easy bruising or bleeding. The liver filters blood, makes clotting proteins and processes nutrients, so liver cancer, often arising in an already diseased liver, can cause abdominal swelling, loss of appetite and jaundice.
General effects such as fatigue, unexplained weight loss and loss of appetite have several causes: anaemia, inflammatory chemicals released by the tumour or the body's response to it, and altered metabolism, which can lead to loss of muscle and fat even when a person is eating. Importantly, all of these symptoms are also common in non-cancerous conditions such as infections, thyroid disorders, diabetes, depression, and digestive problems. Having them does not mean someone has cancer.
Yes. An early cancer is small, and many organs have enough reserve capacity that a small growth does not disturb their function. Many tissues also have few pain-sensitive nerves, so a lack of pain does not exclude cancer. When symptoms do appear, they are often gradual, because slow growth gives the body time to adapt, and people understandably put vague changes down to age, stress or tiredness.
This is why screening exists: testing people who have no symptoms for specific cancers, such as cervical cancer, breast cancer and colorectal cancer, so abnormalities can be found earlier. But screening has limits. It works for some cancers and not others, and who should be screened depends on age, sex, family history, risk factors, and local guidelines, in part to limit false-positive results. There is no single test that screens reliably for every cancer, and not everyone needs the same tests. A doctor can advise which screening, if any, is appropriate for a particular person.
Some symptoms are worth having checked, particularly when they are new, persistent,t or worsening:
• Unexplained weight loss
• Persistent fatigue that does not improve with rest
• A new lump, or one that is growing
• Unusual bleeding, including blood in urine or stools, bleeding between periods or after menopause, or coughing up blood.
• A cough or hoarseness that lasts for weeks
• Changes in bowel or bladder habits
• Skin changes, such as a mole that changes in shape, size or colour, or a sore that does not heal
• Difficulty swallowing
• Persistent pain with no clear explanation
Most people with these symptoms do not have cancer. Most lumps turn out to be cysts, infections or other benign causes, and a cough is far more often a lingering infection or allergy than a tumour. The reason to see a doctor is that the cause should be identified, not that cancer is likely. A sensible rule is to seek evaluation when a symptom lasts several weeks, keeps coming back, or steadily worsens.
Some symptoms need urgent attention regardless: coughing up or vomiting blood, heavy or uncontrolled bleeding, severe breathlessness or chest pain, an inability to swallow even liquids, a sudden severe headache, a new seizure, or sudden weakness or loss of speech. People already undergoing cancer treatment who develop a fever should contact their treating team immediately.
The World Health Organization describes cancer as arising from the interaction between a person's genetic factors and three kinds of external agents: physical carcinogens such as ultraviolet and ionising radiation, chemical carcinogens such as components of tobacco smoke, and biological carcinogens such as certain infections. Within that framework, the main recognised risk factors include:
• Ageing. Cancer becomes much more common with age, probably because exposure to risk factors accumulates while cellular repair becomes less effective.
• Tobacco use. Tobacco smoke contains many chemicals that damage DNA. Smoking is the leading cause of lung cancer and is linked to many other cancers, and second-hand smoke also carries risk.
• Alcohol consumption. Alcohol is linked with cancers of the mouth, throat, liver, breast and bowel, among others.
• Excess body weight and physical inactivity. Both are associated with a higher risk of several cancers, in part through effects on hormones and inflammation.
• Certain infections. Human papillomavirus (HPV) can cause cervical and some throat and anogenital cancers, while chronic hepatitis B and C infection raise the risk of liver cancer. WHO attributes roughly 10% of cancers diagnosed worldwide in 2022 to carcinogenic infections.
• Radiation and environmental exposure. Ultraviolet radiation from sunlight, ionising radiation, radon gas, air pollution, and workplace exposures such as asbestos all contribute.
• Inherited genetic variations. These explain a minority of cancers, but can matter greatly in families with several relatives affected, especially at younger ages.
• A risk factor raises the probability but never makes cancer certain, and some people develop cancer with no identifiable risk factor at all.
Diagnosis is a process, and the tests chosen depend on the person's symptoms and clinical findings. It usually begins with a medical history and physical examination, covering symptoms, family history, and risk factors, followed by a check of the relevant part of the body.
• Blood tests can offer clues, such as anaemia, abnormal liver enzymes, or abnormal blood counts that prompt a closer look for leukaemia. Tumour markers, substances sometimes raised in cancer, can help monitor a known cancer, but they can also be raised by non-cancerous conditions and be normal in people who do have cancer. Blood tests alone rarely diagnose cancer.
• Imaging shows where an abnormality is and how large it is. Ultrasound uses sound waves and is useful for organs such as the breast, liver, and thyroid. CT combines X-rays into cross-sectional images, MRI uses magnetic fields and is especially good for the brain and soft tissues, and PET scans use a small amount of radioactive tracer to highlight areas of high metabolic activity, usually combined with CT. Imaging can point towards cancer but generally cannot confirm it.
• Confirmation usually comes from a biopsy, in which a sample of tissue is removed and examined by a pathologist, a process called histopathology. The pathology report identifies the type of cancer and how abnormal the cells look. For leukaemia, diagnosis relies on blood tests and a bone marrow examination.
• Molecular and biomarker testing analyses the tumour for specific genetic changes or proteins, such as hormone receptors in breast cancer, which can guide targeted treatment. Finally, staging describes how far the cancer has extended: its size, whether lymph nodes are involved, and whether it has spread. Staging helps determine treatment and outlook.
Because cancers differ so much, no single routine test detects all of them.
Most cancer treatments are built on the biology described above.
• Surgery removes the tumour, usually with a margin of normal tissue, and is most useful when the cancer is confined to one area. It can also help diagnose, stage, or relieve symptoms.
• Radiation therapy uses high-energy beams to damage the DNA of cancer cells, which often repair themselves less effectively than healthy cells. Planning aims to focus the dose on the tumour and limit exposure of surrounding tissue.
• Chemotherapy uses drugs that interfere with cell division. Because they act on rapidly dividing cells throughout the body, they can also affect healthy ones, such as those in hair follicles, the gut lining and bone marrow, which explains many side effects.
• Targeted therapy acts on specific molecules that cancer cells depend on, such as an altered growth-signalling protein or the process of blood vessel formation. It is only suitable when a tumour has the relevant feature, which is why biomarker testing matters.
• Immunotherapy helps the immune system recognise and attack cancer cells, as described earlier.
• Hormonal therapy is used for cancers that depend on hormones to grow, such as some breast and prostate cancers, by lowering hormone levels or blocking their effects.
• Treatment plans differ because cancers differ: the best approach depends on the cancer type and stage, its molecular characteristics, the person's overall health, and the goals of treatment, whether cure, control of the disease, or comfort. Treatments are often combined, no treatment guarantees a particular result, and decisions are usually made by a team of specialists together with the patient.
A symptom that persists for several weeks, keeps returning, or is getting worse deserves a medical evaluation, usually starting with a family doctor or physician. Symptoms alone cannot confirm cancer; what they do is prompt a doctor to decide whether tests such as blood work, imaging, or a biopsy are needed. Many people are reassured, and when a problem is found, earlier evaluation generally gives more options.
Patients who already have a cancer diagnosis may have questions about their pathology reports, cancer stage, and recommended treatment options. At Pneuma Care in Noida, Dr. Preeti Chauhan, Consultant in Clinical Oncology, provides cancer care involving chemotherapy, treatment planning, radiation therapy planning, pain and symptom management, palliative care, and second opinions. Patients can explore information about clinical oncology consultations and cancer treatment to better understand the available treatment approaches and the importance of personalised medical guidance. Treatment decisions depend on the cancer type, stage, and individual health condition.
Partly, yes. WHO estimates that around 38% of cancers could currently be prevented by avoiding risk factors and applying existing prevention strategies. The most evidence-based steps are:
• Avoid tobacco and second-hand smoke. This is the single most effective measure for reducing cancer risk.
• Avoid alcohol, or keep it low. Risk generally rises with the amount consumed.
• Maintain a healthy weight and stay physically active.
• Eat a balanced diet, rich in vegetables, fruit, and whole foods.
• Protect your skin from the sun by seeking shade, covering up and using sunscreen, and avoiding tanning devices.
• Get recommended vaccinations. HPV and hepatitis B vaccines protect against infections that can cause cancer, for those in recommended groups.
• Follow occupational safety precautions when working with substances such as asbestos, certain chemicals or radiation.
• Take part in appropriate screening for which you are eligible, based on age, sex, family history and local guidelines.
Reducing risk is not the same as eliminating it. People who do everything right can still develop cancer, partly because chance errors in cell division and unidentified factors are involved, and some people with several risk factors never do. Healthy habits lower the probability; they do not guarantee prevention.
Cancer starts when a single cell acquires genetic changes that disrupt the controls on growth, repair, and cell death. These changes can arise from copying errors during division, from damage caused by substances such as tobacco smoke or ultraviolet radiation, or from inherited variants. Usually several changes must build up in the same cell, and most mutations never lead to cancer.
There is no single answer. For many solid cancers, the journey from the first genetic changes to a diagnosable cancer is thought to take years, often decades, because changes accumulate slowly. Some blood cancers, such as acute leukaemias, can progress over weeks to months once they emerge. Timelines depend on cancer type, genetics and exposures, and cannot be predicted for an individual.
Sometimes. Immune cells can recognise and remove abnormal cells, and this surveillance probably clears many before they cause problems. But cancers that become established have usually found ways to evade or suppress the response. Immunotherapy aims to restore or strengthen it, though it works only in some cancer types and some patients.
No. Benign tumours do not invade nearby tissue or spread, and many never become malignant. Some still need treatment because of their size or position, and certain growths, such as some bowel polyps, can change into cancer over time and are therefore removed. A pathologist examining the tissue determines which kind of tumour it is.
Yes. Many tissues contain few pain-sensitive nerves, and small deposits in organs such as the lungs or liver may cause no discomfort at first. Pain tends to appear when a growth presses on nerves, bone, or the covering of an organ. The absence of pain does not exclude cancer or spread, and pain itself has many non-cancer causes.
No. Most cancers result from mutations acquired during life, through chance errors in cell division or environmental exposures, and are not passed to children. Only a minority are linked to inherited variants. Several relatives with the same or related cancers, or cancer at a young age, may be worth discussing with a doctor, who can advise whether genetic counselling is appropriate.
Not reliably. Routine blood tests can sometimes provide clues, and abnormal blood counts may prompt a closer look for leukaemia, but many cancers, especially early ones, produce normal results. Tumour markers can be raised by non-cancerous conditions and can be normal in cancer, so they are mainly used to monitor known cancer. Diagnosis usually requires imaging and a biopsy.
Cancer develops when the cell's normal controls over growth, repair, and death are gradually eroded by genetic changes. Typically, this takes many steps over many years, which is why it is more common with age, why no single cause explains every case, and why the same disease can behave very differently from person to person.
Understanding this biology helps in practical ways. It explains why symptoms can be absent early on, why screening is useful for some cancers but not all, why diagnosis requires tissue examination and not just a scan, and why treatments are matched to the individual cancer. It also makes clear what a symptom is: a reason to find out the cause, not a diagnosis. When something persistent or unexplained appears, the right response is an informed conversation with a qualified doctor, not self-diagnosis or delay.
0 Comments
Your email address will not be published. Newsletter subscribers are auto-approved; others are moderated for safety.

Team, Acroplus Health - are Medical Content Specialists with expertise in creating accurate, evidence-based, and engaging healthcare content. Skilled in translating complex medical concepts into reader-friendly articles, blogs, and educational resources for patients, healthcare professionals, hospitals, and medical organizations. Passionate about delivering trustworthy information that enhances health awareness and patient education.